Skip to main content
SpringerLink
Log in

Pathogenesis and Aetiology of Female Genital Malformations

  • Chapter
  • First Online:
Female Genital Tract Congenital Malformations

  • 1577 Accesses

Abstract

Aims: To describe the defects of normal embryological development that lie beneath female genital malformations and to review the available data on the possible aetiology of these defects. Brief description of the reviewed data: Female genital malformations are the result of failures in the proper development, canalization, fusion of and re-absorption of the midline septum of the Müllerian ducts. The aetiologies for these anomalies remain mostly unknown. The role of a number of genes has been reviewed, but research has failed to establish an aetiological relationship with a particular mutation. Such malformations appear to be mainly caused by alterations in the expression of developmental genes as a result of exposure to exogenous factors during embryogenesis, like endocrine disruptors. Clinical implications: The lack of findings does not support mutation screening for women with genital malformations. A clinical investigation is important to exclude the presence of an underlying genetic syndrome. A thorough investigation of the anatomy of the reproductive tract is also recommended when prenatal exposure to endocrine disruptors is suspected. Open issues for further research: Future research should aim in elucidating how genes orchestrate a highly organized developmental process. Further investigation is also required to identify additional exogenous estrogenic factors, which alter the expression pattern of fundamental developmental genes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Acien P. Embryological observations on the female genital tract. Hum Reprod. 1992;7:437–45.

    CAS  PubMed  Google Scholar 

  2. Acien P, Acien M, Sanchez-Ferrer M. Complex malformations of the female genital tract: new types and revision of classification. Hum Reprod. 2004;19:2377–84.

    PubMed  Google Scholar 

  3. Akbas GE, Song J, Taylor HS. A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES). J Mol Biol. 2004;340:1013–23.

    CAS  PubMed  Google Scholar 

  4. American Fertility Society. The American Fertility Society classification of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesions. Fertil Steril. 1998;49:944–55.

    Google Scholar 

  5. Ashton D, Amin HK, Richart RM, Neuwirth RS. The incidence of asymptomatic uterine anomalies in women undergoing transcervical tubal sterilization. Obstet Gynecol. 1988;72:28–30.

    CAS  PubMed  Google Scholar 

  6. Aydos S, Tukun A, Bokesoy I. Gonadal dysgenesis and the Mayer-Rokitansky-Kuster-Hauser syndrome in a girl with 46, X, del(X)(pter→q22:). Arch Gynecol Obstet. 2003;267:173–1744.

    CAS  PubMed  Google Scholar 

  7. Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellve AR, Efstratiadis A. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol. 1996;10:903–18.

    CAS  PubMed  Google Scholar 

  8. Barakat AJ. Association of unilateral renal agenesis and genital anomalies. Case Rep Clin Pract Rev. 2002;3:57–60.

    Google Scholar 

  9. Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance. Nature. 1990;345:167–70.

    CAS  PubMed  Google Scholar 

  10. Bendavid C, Pasquier L, Watrin T, Morcel K, Lucas J, Gicquel I, Dubourg C, Henry C, David V, Odent S, Leveque J, Pellerin I, Guerrier D. Phenotypic variability of a 4q34→qter inherited deletion: MRKH syndrome in the daughter, cardiac defect and Fallopian tube cancer in the mother. Eur J Med Genet. 2007;50:66–72.

    PubMed  Google Scholar 

  11. Bernardini L, Gimelli S, Gervasini C, Carella M, Baban A, Frontino G, Barbano G, Divizia MT, Fedele L, Novelli A, Béna F, Lalatta F, Miozzo M, Dallapiccola B. Recurrent microdeletion at 17q12 as a cause of Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome: two case reports. Orphanet J Rare Dis. 2009;4:25.

    PubMed Central  PubMed  Google Scholar 

  12. Bhagavath B, Stelling JR, van Lingen BL, Davos AJ, Reindollar RH, Gray MR. Congenital absence of the uterus and vagina (CAUV) is not associated with the N314D allele of the galactose-1-phosphate uridyl transferase (GALT) gene. J Soc Gynecol Investig. 1998;5:140.

    Google Scholar 

  13. Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ. A WNT4 mutation associated with Müllerian -duct regression and virilisation in a 46,XX woman. N Engl J Med. 2004;351:792–8.

    CAS  PubMed  Google Scholar 

  14. Biason-Lauber A, De Filippo G, Konrad D, Scarano G, Nazzaro A, Schoenle EJ. WNT4 deficiency–a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Hum Reprod. 2007;22:224–9.

    CAS  PubMed  Google Scholar 

  15. Bingham C, Ellard S, Cole TR, Jones KE, Allen LI, Goodship JA, Goodship TH, Bakalinova-Pugh D, Russell GI, Woolf AS, Nicholls AJ, Hattersley AT. Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations. Kidney Int. 2002;61:1243–51.

    CAS  PubMed  Google Scholar 

  16. Block K, Kardana A, Igarashi P, Taylor HS. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing Müllerian system. FASEB J. 2004;14:1101–8.

    Google Scholar 

  17. Burel A, Mouchel T, Odent S, et al. Role of HOXA7 to HOXA13 and PBX1 genes in various forms of MRKH syndrome (congenital absence of uterus and vagina). J Negat Results Biomed. 2006;5:4.

    PubMed Central  PubMed  Google Scholar 

  18. Carta L, Sassoon D. Wnt7a is a suppressor of cell death in the female reproductive tract and is required for postnatal and estrogen-mediated growth. Biol Reprod. 2004;71:444–54.

    CAS  PubMed  Google Scholar 

  19. Chang X, Qin Y, Xu C, Li G, Zhao X, Chen ZJ. Mutations in WNT4 are not responsible for Müllerian duct abnormalities in Chinese women. Reprod Biomed Online. 2012;24:630–3.

    CAS  PubMed  Google Scholar 

  20. Chen G, Shinka T, Kinoshita K, Yan HT, Iwamoto T, Nakahori Y. Roles of estrogen receptor alpha (ER alpha) in the regulation of the human Müllerian inhibitory substance (MIS) promoter. J Med Investig. 2003;50:192–8.

    Google Scholar 

  21. Cheroki C, Krepischi-Santos AC, Rosenberg C, Jehee FS, Mingroni- Netto RC, Pavanello Filho I, Zanforlin Filho S, Kim CA, Bagnoli VR, Mendonca BB, Szuhai K, Otto PA. Report of a del22q11 in a patient with Mayer-Rokitansky-Kuster-Hauser (MRKH) anomaly and exclusion of WNT-4, RAR-gamma, and RXRalpha as major genes determining MRKH anomaly in a study of 25 affected women. Am J Me Genet A. 2006;140:1339–42.

    Google Scholar 

  22. Cheroki C, Krepischi-Santos AC, Szuhai K, Brenner V, Kim CA, Otto PA, Rosenberg C. Genomic imbalances associated with müllerian aplasia. J Med Genet. 2008;45:228–32.

    CAS  PubMed  Google Scholar 

  23. Clark JH, Guthrie SC. The estrogenic effects of clomiphene during the neonatal period in the rat. J Steroid Biochem. 1983;18:513–7.

    CAS  PubMed  Google Scholar 

  24. Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol Endocrinol. 2001;15:946–59.

    CAS  PubMed  Google Scholar 

  25. Clement-Ziza M, Khen N, Gonzales J, Cretolle-Vastel C, Picard JY, Tullio-Pelet A, Besmond C, Munnich A, Lyonnet S, Nihoul-Fekete C. Exclusion of WNT4 as a major gene in Rokitansky-Kuster-Hauser anomaly. Am J Med Genet A. 2005;137:98–9.

    PubMed  Google Scholar 

  26. Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 1999;20:358–417.

    CAS  PubMed  Google Scholar 

  27. Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology. 1997;138:4613–21.

    CAS  PubMed  Google Scholar 

  28. Couse JF, Dixon D, Yates M, Moore AB, Ma L, Maas R, Korach KS. Estrogen receptor-alpha knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract. Dev Biol. 2001;238:224–38.

    CAS  PubMed  Google Scholar 

  29. Cramer DW, Goldstein DP, Fraer C, Reichardt JK. Vaginal agenesis (Mayer Rokitansky-Kuster-Hauser syndrome) associated with the N314D mutation of galactose-1-phosphate uridyltransferase (GALT). Mol Hum Reprod. 1996;2:145–8.

    CAS  PubMed  Google Scholar 

  30. Cunha GR, Taguchi O, Namikawa R, Nishizuka Y, Robboy SJ. Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract. Hum Pathol. 1987;18:1132–43.

    CAS  PubMed  Google Scholar 

  31. Dang Y, Qin Y, Tang R, Mu Y, Li G, Xia M, Chen ZJ. Variants of the WNT7A gene in Chinese patients with müllerian duct abnormalities. Fertil Steril. 2012;97:391–4.

    CAS  PubMed  Google Scholar 

  32. Davis RJ, Harding M, Moayedi Y, Mardon G. Mouse Dach1 and Dach2 are redundantly required for Mullerian duct development. Genesis. 2008;46:205–13.

    CAS  PubMed  Google Scholar 

  33. Devriendt K, Moerman P, Van Schoubroeck D, Vandenberghe K, Fryns JP. Chromosome 22q11 deletion presenting as the Potter sequence. J Med Genet. 1997;34:423–5.

    CAS  PubMed Central  PubMed  Google Scholar 

  34. Devriendt K, Jaeken J, Matthijs G, et al. Haploinsufficiency of the HOXA gene cluster, in a patient with hand-foot-genital syndrome, velopharyngeal insufficiency, and persistent patent ductus botalli. Am J Hum Genet. 1999;65:249–51.

    CAS  PubMed Central  PubMed  Google Scholar 

  35. Du H, Taylor HS. Molecular regulation of mullerian development by Hox genes. Ann N Y Acad Sci. 2004;1034:152–65.

    CAS  PubMed  Google Scholar 

  36. Ekici AB, Strissel PL, Oppelt PG, Renner SP, Brucker S, Beckmann MW, Strick R. HOXA10 and HOXA13 sequence variations in human female genital malformations including congenital absence of the uterus and vagina. Gene. 2013;518:267–72.

    CAS  PubMed  Google Scholar 

  37. Fedele L, Bianchi S, Agnoli B, Tozzi L, Vignali M. Urinary tract anomalies associated with unicornuate uterus. J Urol. 1996;155:847–8.

    CAS  PubMed  Google Scholar 

  38. Fei X, Chung H, Taylor HS. Methoxychlor disrupts uterine Hoxa10 gene expression. Endocrinology. 2005;146:3445–51.

    CAS  PubMed  Google Scholar 

  39. Gervasini C, Grati FR, Lalatta F, Tabano S, et al. SHOX duplications found in some cases with type I Mayer-Rokitansky-Kuster-Hauser syndrome. Genet Med. 2010;12:634–40.

    PubMed  Google Scholar 

  40. Goodman FR. Limb malformations and the human HOX genes. Am J Med Genet. 2002;112:256–65.

    PubMed  Google Scholar 

  41. Goodman FR, Scambler PJ. Human HOX gene mutations. Clin Genet. 2001;59:1–11.

    CAS  PubMed  Google Scholar 

  42. Goodman FR, Bacchelli C, Brady AF, et al. Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet. 2000;67:197–202.

    CAS  PubMed Central  PubMed  Google Scholar 

  43. Grimbizis GF, Gordts S, Di Spiezio Sardo A, Brucker S, De Angelis C, Gergolet M, Li TC, Tanos V, Brölmann H, Gianaroli L, Campo R. The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies. Hum Reprod. 2013;28:2032–44.

    CAS  PubMed Central  PubMed  Google Scholar 

  44. Gu Y, Branham WS, Sheehan DM, Webb PJ, Moland CL, Streck RD. Tissue-specific expression of messenger ribonucleic acids for insulin-like growth factors and insulin-like growth factor-binding proteins during perinatal development of the rat uterus. Biol Reprod. 1999;60:1172–82.

    CAS  PubMed  Google Scholar 

  45. Guerrier D, Mouchel T, Pasquier L, Pellerin I. The Mayer-Rokitansky-Küster-Hauser syndrome (congenital absence of uterus and vagina) – phenotypic manifestations and genetic approaches. J Negat Results Biomed. 2006;5:1.

    PubMed Central  PubMed  Google Scholar 

  46. Guitron-Cantu A, Lopez-Vera E, Forsbach-Sanchez G, Leal-Garza CH, Cortes-Gutierrez EI, Gonzalez-Pico I. Gonadal dysgenesis and Rokitansky syndrome: a case report. J Reprod Med. 1999;44:891–3.

    CAS  PubMed  Google Scholar 

  47. Güven A, Kara N, Sağlam Y, Güneş S, Okten G. The Mayer-Rokitansky-Kuster-Hauser and gonadal dysgenesis anomaly in a girl with 45, X/46, X, del(X)(p11.21). Am J Med Genet A. 2008;146A:128–31.

    PubMed  Google Scholar 

  48. Hammoud AO, Gibson M, Peterson CM, Kerber RA, Mineau GP, Hatasaka H. Quantification of the familial contribution to müllerian anomalies. Obstet Gynecol. 2008;111(2 Pt 1):378–84.

    PubMed  Google Scholar 

  49. Heikkilä M, Prunskaite R, Naillat F, Itäranta P, Vuoristo J, Leppäluoto J, Peltoketo H, Vainio S. The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action. Endocrinology. 2005;146:4016–23.

    PubMed  Google Scholar 

  50. Herbst A, Kurman RJ, Scully RE, Poskanzer DC. Clear-cell adenocarcinoma of the genital tract in young females: registry report. N Engl J Med. 1972;287:1259–64.

    CAS  PubMed  Google Scholar 

  51. Hernández AM, Villamar M, Roselló L, Moreno-Pelayo MA, Moreno F, Del Castillo I. Novel mutation in the gene encoding the GATA3 transcription factor in a Spanish familial case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with female genital tract malformations. Am J Med Genet A. 2007;143:757–62.

    Google Scholar 

  52. Iizuka-Kogo A, Ishidao T, Akiyama T, Senda T. Abnormal development of urogenital organs in Dlgh1-deficient mice. Development. 2007;134:1799–807.

    CAS  PubMed  Google Scholar 

  53. Kitajewski J, Sassoon D. The emergence of molecular gynecology: homeobox and Wnt genes in the female reproductive tract. Bioessays. 2000;22:902–10.

    CAS  PubMed  Google Scholar 

  54. Klipstein S, Bhagavath B, Topipat C, Sasur L, Reindollar RH, Gray MR. The N314D polymorphism of the GALT gene is not associated with congenital absence of the uterus and vagina. Mol Hum Reprod. 2003;9:171–4.

    CAS  PubMed  Google Scholar 

  55. Kobayashi A, Shawlot W, Kania A, Behringer RR. Requirement of Lim1 for female reproductive tract development. Development. 2004;131:539–49.

    CAS  PubMed  Google Scholar 

  56. Kucheria K, Taneja N, Kinra G. Autosomal translocation of chromosomes 12q and 14q in Müllerian duct failure. Indian J Med Res. 1988;87:290–4.

    CAS  PubMed  Google Scholar 

  57. Lalwani S, Wu HH, Reindollar RH, Gray MR. HOXA10 mutations in congenital absence of uterus and vagina. Fertil Steril. 2008;89:325–30.

    CAS  PubMed  Google Scholar 

  58. Ledig S, Schippert C, Strick R, Beckmann MW, Oppelt PG, Wieacker P. Recurrent aberrations identified by array-CGH in patients with Mayer-Rokitansky-Küster-Hauser syndrome. Fertil Steril. 2011;95:1589–94.

    CAS  PubMed  Google Scholar 

  59. Ledig S, Brucker S, Barresi G, Schomburg J, Rall K, Wieacker P. Frame shift mutation of LHX1 is associated with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. Hum Reprod. 2012;27:2872–5.

    CAS  PubMed  Google Scholar 

  60. Liatsikos SA, Grimbizis GF, Georgiou I, Papadopoulos N, Lazaros L, Bontis JN, Tarlatzis BC. HOX A10 and HOX A11 mutation scan in congenital malformations of the female genital tract. Reprod Biomed Online. 2010;21:126–32.

    CAS  PubMed  Google Scholar 

  61. Lindenman E, Shepard MK, Pescovitz OH. Müllerian agenesis: an update. Obstet Gynecol. 1997;90:307–12.

    CAS  PubMed  Google Scholar 

  62. Lindner TH, Njolstad PR, Horikawa Y, Bostad L, Bell GI, Sovik O. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor -1beta. Hum Mol Genet. 1999;8:2001–8.

    CAS  PubMed  Google Scholar 

  63. Ma J, Qin Y, Liu W, Duan H, Xia M, Chen ZJ. Analysis of PBX1 mutations in 192 Chinese women with Müllerian duct abnormalities. Fertil Steril. 2011;95:2615–7.

    CAS  PubMed  Google Scholar 

  64. Ma L, Benson GV, Lim H, Dey SK, Maas RL. Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in müllerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol. 1998;197:141–54.

    CAS  PubMed  Google Scholar 

  65. MacLaughlin DT, Teixeira J, Donahoe PK. Perspective: reproductive tract development – new discoveries and future directions. Endocrinology. 2001;142:2167–72.

    CAS  PubMed  Google Scholar 

  66. Mandel H, Shemer R, Borochowitz ZU, Okopnik M, Knopf C, Indelman M, Drugan A, Tiosano D, Gershoni-Baruch R, Choder M, Sprecher E. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. Am J Hum Genet. 2008;82:39–47.

    CAS  PubMed Central  PubMed  Google Scholar 

  67. Massé J, Watrin T, Laurent A, Deschamps S, Guerrier D, Pellerin I. The developing female genital tract: from genetics to epigenetics. Int J Dev Biol. 2009;53:411–24.

    PubMed  Google Scholar 

  68. McCormack S, Clark JH. Clomid administration to pregnant rats causes abnormalities of the reproductive tract in offspring and mothers. Science. 1979;204:629–31.

    CAS  PubMed  Google Scholar 

  69. Mendelsohn C, Lohnes D, Décimo D, Lufkin T, LeMeur M, Chambon P, Mark M. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development. 1994;120:749–2771.

    Google Scholar 

  70. Miller C, Sassoon DA. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development. 1998;125:3201–11.

    CAS  PubMed  Google Scholar 

  71. Miller C, Pavlova A, Sassoon DA. Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mech Dev. 1998;76:91–9.

    CAS  PubMed  Google Scholar 

  72. Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S. Defects of urogenital development in mice lacking Emx2. Development. 1997;124:1653–64.

    CAS  PubMed  Google Scholar 

  73. Mohapatra I, Ammini AC, Taneja N, Mitra DK, Kucheria K. Gonadal dysgenesis with no uterus or vagina in a female: a case report. J Reprod Med. 1992;37:177–80.

    CAS  PubMed  Google Scholar 

  74. Moore KL, Persaud TVN, Torchia MG. The urogenital system. Before we are born: essential of embryology and birth defects. 7th ed. Philadelphia: Saunders/Elsevier; 2008. p. 162–89.

    Google Scholar 

  75. Mortlock DP, Innis JW. Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet. 1997;15:179–80.

    CAS  PubMed  Google Scholar 

  76. Nagao T, Yoshimura S. Oral administration of clomiphene to neonatal rats causes reproductive tract abnormalities. Teratog Carcinog Mutagen. 2001;21:213–21.

    CAS  PubMed  Google Scholar 

  77. Nakamura A, Fujiwara F, Hasegawa Y, Ishizu K, Mabe A, Nakagawa H, Nagasaki K, Jo W, Tajima T. Molecular analysis of the GATA3 gene in five Japanese patients with HDR syndrome. Endocr J. 2011;58:123–30.

    CAS  PubMed  Google Scholar 

  78. Nik-Zainal S, Strick R, Storer M, Huang N, Ra R, Willatt L, Fitzgerald T, Martin V, Sandford R, Carter NP, Janecke AR, Renner SP, Oppelt PG, Oppelt P, Schulze C, Brucker S, Hurles M, Beckmann MW, Strissel PL, Shaw-Smith C. High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasia. J Med Genet. 2011;48:197–204.

    PubMed Central  PubMed  Google Scholar 

  79. Okada A, Sato T, Ohta Y, Iguchi T. Sex steroid hormone receptors in the developing female reproductive tract of laboratory rodents. J Toxicol Sci. 2005;30:75–89.

    CAS  PubMed  Google Scholar 

  80. Oppelt P, Strissel PL, Kellermann A, Seeber S, Humeny A, Beckmann MW, Strick R. DNA sequence variations of the entire anti-Müllerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer-Rokitanski-Kuster-Hauser syndrome. Hum Reprod. 2005;20:149–57.

    CAS  PubMed  Google Scholar 

  81. Resendes BL, Sohn SH, Stelling JR, Tineo R, Davis AJ, Gary MR, Reindollar RH. Role for anti-Müllerian hormone in congenital absence of the uterus and vagina. Am J Med Genet. 2001;98:129–36.

    CAS  PubMed  Google Scholar 

  82. Roberts LM, Visser JA, Ingraham HA. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development. 2002;129:1487–96.

    CAS  PubMed  Google Scholar 

  83. Sandbacka M, Painter J, Puhakka M, Halttunen M, Laivuori H, Aittomäki K. Does the Y chromosome have a role in Müllerian aplasia? Fertil Steril. 2010;94:120–5.

    CAS  PubMed  Google Scholar 

  84. Sandbacka M, Halttunen M, Jokimaa V, Aittomäki K, Laivuori H. Evaluation of SHOX copy number variations in patients with Müllerian aplasia. Orphanet J Rare Dis. 2011;6:53.

    PubMed Central  PubMed  Google Scholar 

  85. Scheuerle A. Teenager with uterine didelphys, absent kidney and 22q11.2 deletion. Am J Med Genet A. 2008;146A:800–1.

    PubMed  Google Scholar 

  86. Simpson JL. Genetics of the female reproductive ducts. Am J Med Genet. 1999;89:224–439.

    CAS  PubMed  Google Scholar 

  87. Smith CC, Taylor HS. Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development. FASEB J. 2007;21:239–46.

    CAS  PubMed  Google Scholar 

  88. Stelling JR, Bhagavah B, Gray MR, Reindollar RH. HOXA13 Homeodomain mutation analysis in patients with Mullerian system anomalies. J Soc Gynecol Investig. 1998;5:140A.

    Google Scholar 

  89. Sundaram UT, McDonald-McGinn DM, Huff D, Emanuel BS, Zackai EH, Driscoll DA, Bodurtha J. Primary amenorrhea and absent uterus in the 22q11.2 deletion syndrome. Am J Med Genet A. 2007;143A:2016–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  90. Timmreck LS, Gray MR, Handelin B, Allito B, Rohlfs E, Davis AJ, Gidwani G, Reindollar RH. Analysis of cystic fibrosis transmembrane conductance regulator gene mutations in patients with congenital absence of the uterus and vagina. Am J Med Genet A. 2003;120:72–6.

    Google Scholar 

  91. Timmreck LS, Pan HA, Reindollar RH, Gray MR. WNT7A mutations in patients with Müllerian duct abnormalities. J Pediatr Adolesc Gynecol. 2003;16:217–21.

    CAS  PubMed  Google Scholar 

  92. Torres M, Gomez-Pardo E, Dressler GR, Gruss P. Pax-2 controls multiple steps of urogenital development. Development. 1995;121:4057–65.

    CAS  PubMed  Google Scholar 

  93. Uliana V, Giordano N, Caselli R, Papa FT, Ariani F, Marcocci C, Gianetti E, Martini G, Papakostas P, Rollo F, Meloni I, Mari F, Priolo M, Renieri A, Nuti R. Expanding the phenotype of 22q11 deletion syndrome: the MURCS association. Clin Dysmorphol. 2008;17:13–7.

    PubMed  Google Scholar 

  94. Utsch B, Becker K, Brock D, et al. A novel stable polyalanine [poly(A)] expansion in the HOXA13 gene associated with hand-foot-genital syndrome: proper function of poly(A) harbouring transcription factors depends on a critical repeat length? Hum Genet. 2002;110:488–94.

    CAS  PubMed  Google Scholar 

  95. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP. Female development in mammals is regulated by Wnt-4 signalling. Nature. 1999;397:405–9.

    CAS  PubMed  Google Scholar 

  96. van Lingen BL, Eccles MR, Reindollar H, Gray MR. Further evidence that the WT1 gene does not have a role in the development of the derivatives of the Müllerian duct. Am J Obstet Gynecol. 1998;179:597–603.

    PubMed  Google Scholar 

  97. van Lingen BL, Reindollar RH, Davis AJ, Gray MR. Molecular genetic analysis of the PAX2 gene in patients with congenital absence of the uterus and vagina. Fertil Steril. 1998;70:S402 (abstract).

    Google Scholar 

  98. Wagner J, Lehmann L. Estrogens modulate the gene expression of Wnt-7a in cultured endometrial adenocarcinoma cells. Mol Nutr Food Res. 2006;50:368–72.

    CAS  PubMed  Google Scholar 

  99. Wang P, Zhao H, Sun M, Li Y, Chen ZJ. PAX2 in 192 Chinese women with Müllerian duct abnormalities: mutation analysis. Reprod Biomed Online. 2012;25:219–22.

    CAS  PubMed  Google Scholar 

  100. Wu K, Chang X, Wei D, Xu C, Qin Y, Chen ZJ. Lack of association of WNT5A mutations with Müllerian duct abnormalities. Reprod Biomed Online. 2013;26:164–7.

    CAS  PubMed  Google Scholar 

  101. Xia M, Zhao H, Qin Y, Mu Y, Wang J, Bian Y, Ma J, Chen ZJ. LHX1 mutation screening in 96 patients with müllerian duct abnormalities. Fertil Steril. 2012;97:682–5.

    CAS  PubMed  Google Scholar 

  102. Yin Y, Ma L. Development of the mammalian female reproductive tract. J Biochem. 2005;137:677–83.

    CAS  PubMed  Google Scholar 

  103. Zenteno JC, Carranza-Lira S, Kofman-Alfaro S. Molecular analysis of the anti-Müllerian hormone, the anti-Müllerian hormone receptor, and galactose-1-phosphate uridyl transferase genes in patients with the Mayer-Rokitansky-Küster-Hauser syndrome. Arch Gynecol Obstet. 2004;269:270–3.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Reproduction and Advanced Technology, CREATE Health Clinics, St Georges House, 3-5 Pepys Road, West Wimbledon, London, SW20 8NJ, UK

    Spiros A. Liatsikos MD, PhD

Authors
  1. Spiros A. Liatsikos MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Spiros A. Liatsikos MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki Medical School, Thessaloniki, Thessaloniki, Greece

    Grigoris F. Grimbizis

  2. Obstetrics and Gynaecology, Genk Institute for Fertility Technology, Leuven, Belgium

    Rudi Campo

  3. Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki Medical School, Thessaloniki, Thessaloniki, Greece

    Basil C. Tarlatzis

  4. Leuven Institute for Fertility & Embryology, Leuven, Belgium

    Stephan Gordts

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Liatsikos, S.A. (2015). Pathogenesis and Aetiology of Female Genital Malformations. In: Grimbizis, G., Campo, R., Tarlatzis, B., Gordts, S. (eds) Female Genital Tract Congenital Malformations. Springer, London. https://doi.org/10.1007/978-1-4471-5146-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5146-3_2

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5145-6

  • Online ISBN: 978-1-4471-5146-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation